ThermoGenesis Holdings, Inc(NASDAQ:THMO) 
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology...
Website: http://www.thermogenesis.com
Founded: 1986
Full Time Employees: 50
CEO: Xiao Chun Xu
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.00
H 0.00
L 0.00
C 0.00
V 0
10EMA
20EMA
60EMA
120EMA
250EMA